bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 20, 2024
Abstract
The
growing
body
of
experimental
and
computational
studies
suggested
that
the
cross-neutralization
antibody
activity
against
Omicron
variants
may
be
driven
by
balance
tradeoff
multiple
energetic
factors
interaction
contributions
evolving
escape
hotspots
involved
in
antigenic
drift
convergent
evolution.
However,
dynamic
details
quantifying
contribution
these
factors,
particularly
balancing
nature
specific
interactions
formed
antibodies
with
epitope
residues
remain
scarcely
characterized.
In
this
study,
we
performed
molecular
dynamics
simulations,
ensemble-based
deep
mutational
scanning
SARS-CoV-2
spike
binding
free
energy
computations
for
two
distinct
groups
broadly
neutralizing
:
E1
group
(BD55-3152,
BD55-3546
BD5-5840)
F3
(BD55-3372,
BD55-4637
BD55-5514).
Using
approaches,
examine
determinants
which
potent
can
largely
evade
immune
resistance.
Our
analysis
revealed
emergence
a
small
number
positions
correspond
to
R346
K444
strong
van
der
Waals
act
synchronously
leading
large
contribution.
According
our
results,
Abs
effectively
exploit
hotspot
clusters
hydrophobic
sites
critical
functions
along
selective
complementary
targeting
positively
charged
are
important
ACE2
binding.
Together
conserved
epitopes,
lead
expanded
neutralization
breadth
resilience
shift
associated
viral
results
study
demonstrate
excellent
qualitative
agreement
between
predicted
mutations
respect
latest
experiments
on
average
scores.
We
argue
epitopes
leverage
stability
binding,
while
tend
emerge
synergistically
electrostatic
interactions.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 5, 2024
SUMMARY
During
the
summer
of
2024,
COVID-19
cases
surged
globally,
driven
by
variants
derived
from
JN.1
subvariants
SARS-CoV-2
that
feature
new
mutations,
particularly
in
N-terminal
domain
(NTD)
spike
protein.
In
this
study,
we
report
on
neutralizing
antibody
(nAb)
escape,
infectivity,
fusion,
and
stability
these
subvariants—LB.1,
KP.2.3,
KP.3,
KP.3.1.1.
Our
findings
demonstrate
all
are
highly
evasive
nAbs
elicited
bivalent
mRNA
vaccine,
XBB.1.5
monovalent
mumps
virus-based
or
infections
during
BA.2.86/JN.1
wave.
This
reduction
nAb
titers
is
primarily
a
single
serine
deletion
(DelS31)
NTD
spike,
leading
to
distinct
antigenic
profile
compared
parental
other
variants.
We
also
found
DelS31
mutation
decreases
pseudovirus
infectivity
CaLu-3
cells,
which
correlates
with
impaired
cell-cell
fusion.
Additionally,
protein
appears
more
conformationally
stable,
as
indicated
reduced
S1
shedding
both
without
stimulation
soluble
ACE2,
increased
resistance
elevated
temperatures.
Molecular
modeling
suggests
induces
conformational
change
stabilizes
strengthens
NTD-Receptor-Binding
Domain
(RBD)
interaction,
thus
favoring
down
conformation
RBD
reducing
accessibility
ACE2
receptor
certain
nAbs.
introduces
an
N-linked
glycan
modification
at
N30,
shields
underlying
region
recognition.
data
highlight
critical
role
mutations
for
evasion,
stability,
viral
suggest
consideration
updating
vaccines
antigens
containing
DelS31.
Cell,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 1, 2024
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
evolution
has
resulted
in
viral
escape
from
clinically
authorized
monoclonal
antibodies
(mAbs),
creating
a
need
for
mAbs
that
are
resilient
to
epitope
diversification.
Broadly
neutralizing
sufficiently
potent
clinical
development
and
retain
activity
despite
remain
elusive.
We
identified
human
mAb,
designated
VIR-7229,
which
targets
the
receptor-binding
motif
(RBM)
with
unprecedented
cross-reactivity
all
sarbecovirus
clades,
including
non-ACE2-utilizing
bat
sarbecoviruses,
while
potently
SARS-CoV-2
variants
since
2019,
recent
EG.5,
BA.2.86,
JN.1.
VIR-7229
tolerates
extraordinary
variability,
partly
attributed
its
high
binding
affinity,
receptor
molecular
mimicry,
interactions
RBM
backbone
atoms.
Consequently,
features
barrier
selection
of
mutants,
rare
associated
reduced
fitness,
underscoring
potential
be
future
evolution.
is
strong
candidate
become
next-generation
medicine.
Biomolecules,
Journal Year:
2025,
Volume and Issue:
15(2), P. 249 - 249
Published: Feb. 8, 2025
A
growing
body
of
experimental
and
computational
studies
suggests
that
the
cross-neutralization
antibody
activity
against
Omicron
variants
may
be
driven
by
balance
tradeoff
between
multiple
energetic
factors
interaction
contributions
evolving
escape
hotspots
involved
in
antigenic
drift
convergent
evolution.
However,
dynamic
details
quantifying
contribution
these
factors,
particularly
balancing
nature
specific
interactions
formed
antibodies
with
epitope
residues,
remain
largely
uncharacterized.
In
this
study,
we
performed
molecular
dynamics
simulations,
an
ensemble-based
deep
mutational
scanning
SARS-CoV-2
spike
binding
free
energy
computations
for
two
distinct
groups
broadly
neutralizing
antibodies:
E1
group
(BD55-3152,
BD55-3546,
BD5-5840)
F3
(BD55-3372,
BD55-4637,
BD55-5514).
Using
approaches,
examined
determinants
which
potent
can
evade
immune
resistance.
Our
analysis
revealed
emergence
a
small
number
positions
correspond
to
R346
K444
strong
van
der
Waals
act
synchronously,
leading
large
contribution.
According
our
results,
Abs
effectively
exploit
hotspot
clusters
hydrophobic
sites
are
critical
functions
along
selective
complementary
targeting
positively
charged
important
ACE2
binding.
Together
conserved
epitopes,
lead
expand
breadth
resilience
neutralization
shifts
associated
viral
The
results
study
demonstrate
excellent
qualitative
agreement
predicted
mutations
respect
latest
experiments
on
average
scores.
We
argue
epitopes
leverage
stability
binding,
while
tend
emerge
synergistically
electrostatic
interactions.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(4), P. e0320891 - e0320891
Published: April 7, 2025
The
COVID-19
pandemic
offered
an
unprecedented
glimpse
into
the
evolution
of
its
causative
virus,
SARS-CoV-2.
It
has
been
estimated
that
since
outbreak
in
late
2019,
virus
explored
all
possible
alternatives
terms
missense
mutations
for
sites
polypeptide
chain.
Spike
protein
exhibits
largest
sequence
variation
particular,
with
many
individual
impacting
target
recognition,
cellular
entry,
and
endosomal
escape
virus.
Moreover,
recent
studies
unveiled
a
significant
increase
total
charge
on
spike
during
initial
period
pandemic.
While
this
trend
recently
come
to
halt,
we
perform
sequence-based
analysis
2665
SARS-CoV-2
variants
which
shows
ionizable
amino
acids
continue
occur
newly
emerging
variants,
notable
differences
between
lineages
from
different
clades.
What
is
more,
show
within
can
acquire
positive
charge,
prominent
preference
lysine
residues
over
arginine
residues.
This
lysine-to-arginine
ratio
increased
at
several
points
evolution,
most
BA.2.86
sublineages,
including
dominant
JN.1,
KP.3,
XEC
variants.
consequence
structural
regions
now
among
highest
viral
species
Coronaviridae
family.
impact
high
proteins
daughter
fitness
remains
unclear;
discuss
potential
mechanisms
could
play
role
serve
as
starting
point
further
studies.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 17, 2025
Abstract
Evolution
of
SARS-CoV-2
has
led
to
the
emergence
variants
with
increased
immune
evasion
capabilities,
posing
significant
challenges
antibody-based
therapeutics
and
vaccines.
The
cross-neutralization
activity
antibodies
against
Omicron
is
governed
by
a
complex
delicate
interplay
multiple
energetic
factors
interaction
contributions.
In
this
study,
we
conducted
comprehensive
analysis
interactions
between
receptor-binding
domain
(RBD)
spike
protein
four
neutralizing
S309,
S304,
CYFN1006,
VIR-7229.
Using
integrative
computational
modeling
that
combined
all-atom
molecular
dynamics
(MD)
simulations,
mutational
scanning,
MM-GBSA
binding
free
energy
calculations,
elucidated
structural,
energetic,
dynamic
determinants
antibody
binding.
Our
findings
reveal
distinct
mechanisms
evolutionary
adaptation
driving
broad
neutralization
effect
these
antibodies.
We
show
S309
targets
conserved
residues
near
ACE2
interface,
leveraging
synergistic
van
der
Waals
electrostatic
interactions,
while
S304
focuses
on
fewer
but
sensitive
residues,
making
it
more
susceptible
escape
mutations.
CYFN-1006.1
CYFN-1006.2
highlights
epitope
coverage
critical
anchors
at
T345,
K440,
T346,
enhancing
its
efficacy
carrying
K356T
mutation
which
caused
from
broadly
potent
VIR-7229
XBB.1.5
EG.5
emphasized
large
structurally
epitope,
demonstrating
certain
adaptability
compensatory
effects
F456L
L455S
Mutational
profiling
identified
key
crucial
for
binding,
including
P337,
R346
T385
K386
underscoring
their
roles
as
"weak
spots"
balance
viral
fitness
evasion.
results
demonstrate
good
agreement
predicted
hotspots
mutations
respect
latest
experiments
average
scores.
study
dissect
importance
targeting
diverse
epitopes
counteract
resistance.
Broad-spectrum
CYFN1006
maintain
across
achieve
convergent
evolution
enabling
tolerance
in
positions
through
structural
interface.
underscore
diversity
employed
different
basis
high
affinity
excellent
generation
mSphere,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 24, 2025
ABSTRACT
Recent
advancements
in
synthetic
biology
and
sequencing
technologies
have
revolutionized
the
ability
to
manipulate
viral
genomes
with
unparalleled
precision.
This
review
focuses
on
two
powerful
methodologies:
deep
mutational
scanning
CRISPR-based
genome
editing,
that
enable
comprehensive
mutagenesis
detailed
functional
characterization
of
proteins.
These
approaches
significantly
deepened
our
understanding
molecular
determinants
driving
evolution
adaptation.
Furthermore,
we
discuss
how
these
advances
provide
transformative
insights
for
future
vaccine
development
therapeutic
strategies.
Immunological Reviews,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 27, 2024
The
SARS-CoV-2
spike
(S)
protein
has
undergone
significant
evolution,
enhancing
both
receptor
binding
and
immune
evasion.
In
this
review,
we
summarize
ongoing
efforts
to
develop
antibodies
targeting
various
epitopes
of
the
S
protein,
focusing
on
their
neutralization
potency,
breadth,
escape
mechanisms.
Antibodies
receptor-binding
site
(RBS)
typically
exhibit
high
neutralizing
potency
but
are
frequently
evaded
by
mutations
in
variants.
contrast,
conserved
regions,
such
as
S2
stem
helix
fusion
peptide,
broader
reactivity
generally
lower
potency.
However,
several
broadly
have
demonstrated
exceptional
efficacy
against
emerging
variants,
including
latest
omicron
subvariants,
underscoring
potential
vulnerable
sites
RBS-A
RBS-D/CR3022.
We
also
highlight
public
classes
different
protein.
targeted
present
opportunities
for
germline-targeting
vaccine
strategies.
Overall,
developing
escape-resistant,
potent
effective
vaccines
remains
crucial
combating
future
This
review
emphasizes
importance
identifying
key
utilizing
antibody
affinity
maturation
inform
therapeutic
design.